Tredje AP-fonden’s Strongbridge Biopharma plc. SBBP Stock Holding History

Tredje AP-fonden’s Portfolio SBBP Stock Details SBBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-71,115	Closed	-$155K	–	418
2019 Q4	$155K	Sell	71,115 -16,471	-19%	-$31.6K	0.01%	396
2019 Q3	$209K	Sell	87,586 -63,235	-42%	-$170K	0.01%	393
2019 Q2	$489K	Sell	150,821 -22,072	-13%	-$81K	0.02%	370
2019 Q1	$873K	Sell	172,893 -17,102	-9%	-$84.2K	0.05%	314
2018 Q4	$851K	Sell	189,995 -27,602	-13%	-$135K	0.05%	295
2018 Q3	$1.05M	Sell	217,597 -7,403	-3%	-$37.9K	0.05%	297
2018 Q2	$1.35M	Sell	225,000 -200,000	-47%	-$1.46M	0.05%	316
2018 Q1	$4.2M	Sell	425,000 -439,400	-51%	-$3.29M	0.15%	177
2017 Q4	$6.27M	Hold	864,400	–	–	0.21%	115
2017 Q3	$6.06M	Sell	864,400 -45,181	-5%	-$312K	0.21%	117
2017 Q2	$6.5M	Hold	909,581	–	–	0.24%	111
2017 Q1	$4.32M	Hold	909,581	–	–	0.17%	170
2016 Q4	$2.18M	Hold	909,581	–	–	0.09%	274
2016 Q3	$4.75M	Hold	909,581	–	–	0.21%	115
2016 Q2	$3.62M	Hold	909,581	–	–	0.16%	152
2016 Q1	$5.07M	Hold	909,581	–	–	0.23%	96
2015 Q4	$6.91M	Buy	+909,581	New	+$6.54M	0.44%	55

Other funds holding SBBP

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Tredje AP-fonden's SBBP Position: Q1 2020 in Review

Tredje AP-fonden sold out of Strongbridge Biopharma plc. (SBBP) in Q1 2020, closing a stake of 71,115 shares — an estimated $155K sold.

Tredje AP-fonden first reported a position in SBBP in Q4 2015 and held it in 17 quarters. The position peaked at $6.91M in Q4 2015. 60 funds tracked by Wall St. Rank hold SBBP as of Q1 2020.

Tredje AP-fonden reported no remaining Strongbridge Biopharma plc. position as of Q1 2020 after selling out during the quarter.
Tredje AP-fonden sold 71,115 Strongbridge Biopharma plc. shares in Q1 2020, an estimated $155K.
Tredje AP-fonden first reported a position in Strongbridge Biopharma plc. in Q4 2015 and held it in 17 quarters.
Tredje AP-fonden's Strongbridge Biopharma plc. position peaked at $6.91M in Q4 2015.
60 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q1 2020.

Based on Tredje AP-fonden's 13F filing for Q1 2020, filed 11 May 2020.